Background {#Sec1}
==========

Chronic and excessive alcohol consumption is a major cause of death around the world. Regular alcohol consumption can lead to steatosis, steatohepatitis, liver cirrhosis, and hepatocellular carcinoma \[[@CR1]--[@CR3]\]. Liver transplantation (LT) is an extended treatment for end-stage liver diseases; alcoholic liver cirrhosis is the second most frequent cause for LT in the United States and in Europe \[[@CR4]\]. Previous studies demonstrated that LT in ALD patients offers an equal survival rate as that in other causes of end-stage liver disease \[[@CR5]\]. Furthermore, LT for severe alcoholic hepatitis has a favorable outcome and better survival than medical therapy, but non-surgical therapy remains the standard of care for patients with severe alcoholic hepatitis \[[@CR6], [@CR7]\].

The issues of recidivism and disease recurrence remain a concern in LT for alcoholic liver disease. Alcohol relapse negatively impacts outcomes including graft rejection and graft loss from poor medical compliance, post-transplant malignancy, cardiovascular diseases, alcoholic cirrhosis, and decreased long-term survival \[[@CR8]--[@CR11]\]. An abstinence period of at least 6 months before LT is a mandatory selection criterion in most liver transplant centers, but the benefit of such pre-transplant 6 month abstinence remains unclear \[[@CR8], [@CR12], [@CR13]\]. Furthermore, there are subsequent reports indicating that an abstinence period of 6 months is not a significant predictive factor for recidivism \[[@CR14]--[@CR16]\]. Careful evaluation of patients with alcoholic liver disease prior to liver transplantation can identify patients with a high risk of alcohol relapse. Modifying the negative factors before LT can prevent alcohol relapse and improve post-transplant survival.

Most of these studies on alcohol recidivism after LT were done in single centers and were reported as descriptive data \[[@CR16]--[@CR24]\]. A previously published meta-analysis study of alcohol relapse after liver transplantation by Dew et al. in 2008 only included published reports on this topic up to 2004 \[[@CR25]\]. Several predictive factors have been reported in the last decade \[[@CR8], [@CR14], [@CR15], [@CR25], [@CR26]\]. Thus, we performed a systematic review and meta-analysis from the published literature with the following objectives: First, to pool prevalence of alcohol relapse after LT; second, to explore factors associated with alcohol relapse and pool their magnitude of effects in alcoholic liver disease patients with LT.

Methods {#Sec2}
=======

This meta-analysis was conducted by following the Preferred Reporting Items for Systematic Reviews and Meta-analysis (PRISMA) guidelines, and the review protocol was registered at PROSPERO (CRD42017052659).

Search strategy {#Sec3}
---------------

Two investigators (L.C. and A.S.) independently conducted a search of databases via MEDLINE and SCOPUS via PubMed and Scopus search engines to identify relevant studies published up to 31 March 2018. The search terms were constructed by domains of patients, intervention/exposure, and outcome. The search strategy is outlined in Table [1](#Tab1){ref-type="table"}. The investigators supplemented the manual reviews of article reference lists to identify studies that had not been included from the initial database search and also performed manual reviews of the relevant studies. Table 1Search terms and search strategyDomainSearch termSearch strategyP-Patient- "Alcoholic hepatitis"\#1- "Alcoholic liver disease"\#2- "Alcoholic cirrhosis"\#3- "Liver transplantation"\#4- "Hepatic transplantation"\#5All P\#6\#1 OR \#2 OR \#3 AND \#4 OR \#5E-Exposure (I-intervention/C-comparator)- Gender\#7- Sex\#8\#9\#7 OR \#8- Age\#10- "Marital status"\#11- Divorced\#12\#13\#11 OR \#12- "Socioeconomic status"\#14- Income\#15- Education\#16\#17\#14 OR \#15 OR \#16- "Alcohol dependence"\#18- Depression\#19- "Drug use"\#20- "Substance use"\#21- "Substance abuse"\#22- substance\#23\#24\#20 OR \#21 OR \#22 OR \#23- Family history of alcohol\#25- Alcohol abstinence\#26- Alcohol cessation\#27- Alcohol quit\#28- Alcohol stop\#29- Alcohol sobriety\#30\#31\#26 OR \#27 OR \#28 OR \#29 OR \#30- Rehabilitation\#32- High Risk Alcoholism Relapse\#33- HRAR\#34\#35\#33 OR \#34All E\#36\#9 OR \#10 OR \#13 OR \#17 OR \#18 OR \#19 OR \#24 OR \#25 OR \#31 OR \#32 OR \#35O-Outcome- Alcohol relapse\#37- Alcohol recurrence\#38- Recidivism\#39All O\#40\#37 OR \#38 OR \#39Overall\#6 AND \#36 AND \#40

Study selection {#Sec4}
---------------

Two investigators (L.C. and A.S.) determined the eligibility of each article for inclusion by screening for relevance on titles and abstracts in parallel. If an eligibility of the study was indeterminable from abstracts, then the full articles were retrieved. The kappa statistic was used to estimate the agreement between the two reviewers \[[@CR27]\]. Discordant decisions between the two investigators were advanced to full-text review and resolved by consensus with the third investigator (A.T.).

Inclusion criteria {#Sec5}
------------------

### Studies were eligible if they met all of the following criteria {#Sec6}

The study was an observational design including cohort, cross-sectional, or case-control study published as an original article.The work studied adult patients aged over 18 years with alcoholic liver disease who underwent any type of LT.Reporting any of the following outcomes: alcohol relapse or alcohol recurrence.The study assessed association between alcohol relapse and any risk factor including seven domains as follows: demographic data, psychiatric conditions, socioeconomic status, family support, alcohol abstinence, rehabilitation program, and high-risk alcohol relapse (HRAR) scale \[[@CR28]\].

### Exclusion criteria {#Sec7}

Studies were excluded if they met one of the below criteria: Non-English articles that cannot be translated.Studies with multi-organ transplantation.Insufficient data for extraction.

### Outcome of interest {#Sec8}

The outcome of interest was alcohol relapse and heavy alcohol relapse in patients who underwent LT for alcoholic liver disease. We selected papers on the occurrence of alcohol relapse based on the original authors' definition of alcohol relapse and heavy relapse and used several methods of relapse assessment such as self-reporting and collateral reporting except for biochemical testing and indirect measures. In general, alcohol relapse was defined as any alcohol consumption post-transplantation, and heavy alcohol relapse was defined as a relapse of alcohol consumption associated with significant medical or social harm \[[@CR29]\].

### Data extraction {#Sec9}

Data obtained from each study was independently extracted by two reviewers (L.C. and A.S.) using a standardized extraction form. Study design, details of the publication, the number of subjects, and baseline characteristics of study populations were extracted including patients with alcohol relapse and predictive factors of alcohol relapse after LT.

### Quality and risk of bias assessment {#Sec10}

All selected studies were independently reviewed by two investigators (L.C. and A.S.). Disagreements between the two reviewers were resolved by consensus with the third investigator (A.T.). Quality was assessed using a Newcastle-Ottawa Scale for eligible studies including selection, exposure, and comparability of studies on the basis of the design or analysis and assessment of the outcomes (Table [2](#Tab2){ref-type="table"}). Table 2Newcastle-Ottawa quality assessment scale of each included studiesAuthorYearS1S2S3S4CO1O2O3Starzl TE \[[@CR30]\]1988✹✹✹✹✹Bird GLA \[[@CR12]\]1990✹✹✹✹✹✹✹Kumar S \[[@CR31]\]1990✹✹✹✹✹✹✹✹Doffoel M\[[@CR32]\]1992✹✹✹✹✹Knechtle SJ \[[@CR33]\]1992✹✹✹✹✹✹✹Lucey MR \[[@CR34]\]1992✹✹✹✹✹✹✹✹✹Berlakovich GA \[[@CR35]\]1994✹✹✹✹✹✹✹Howard L \[[@CR36]\]1994✹✹✹✹✹✹✹Osorio RW \[[@CR37]\]1994✹✹✹✹✹✹✹✹Gerhardt TC \[[@CR38]\]1996✹✹✹✹✹✹✹✹Tringali RA \[[@CR39]\]1996✹✹✹✹✹✹✹✹Tripp LE \[[@CR40]\]1996✹✹✹✹✹Zibari GB \[[@CR41]\]1996✹✹✹✹✹✹✹Anand AC \[[@CR42]\]1997✹✹✹✹✹✹✹Coffman KL \[[@CR43]\]1997✹✹✹✹✹Everson G \[[@CR44]\]1997✹✹✹✹✹✹Foster PF \[[@CR24]\]1997✹✹✹✹✹✹✹✹Lucey MR \[[@CR45]\]1997✹✹✹✹✹✹✹✹Reeck UH \[[@CR46]\]1997✹✹✹✹Shakil AO \[[@CR47]\]1997✹✹✹✹✹Stefanini GF \[[@CR48]\]1997✹✹✹✹✹DiMartini A \[[@CR49]\]1998✹✹✹✹Fabrega E \[[@CR50]\]1998✹✹✹✹✹✹✹Heinemann A \[[@CR51]\]1998✹✹✹✹✹✹✹Tang H \[[@CR52]\]1998✹✹✹✹✹✹Conjeevaram HS \[[@CR53]\]1999✹✹✹✹✹✹✹✹Gledhill J \[[@CR54]\]1999✹✹✹✹✹✹✹Newton SE \[[@CR55]\]1999✹✹✹✹Pageaux GP \[[@CR18]\]1999✹✹✹✹✹✹✹✹Romano DR \[[@CR56]\]1999✹✹✹✹✹✹✹Abosh D \[[@CR57]\]2000✹✹✹✹Berlakovich GA \[[@CR58]\]2000✹✹✹✹✹✹✹✹Burra P \[[@CR59]\]2000✹✹✹✹✹✹✹✹DiMartini A \[[@CR60]\]2000✹✹✹✹✹✹✹Jain A \[[@CR61]\]2000✹✹✹✹✹✹✹✹✹Pereira SP \[[@CR62]\]2000✹✹✹✹✹✹✹Platz KP \[[@CR21]\]2000✹✹✹✹✹✹✹Bellamy CO \[[@CR63]\]2001✹✹✹✹✹✹✹DiMartini A \[[@CR64]\]2001✹✹✹✹✹✹✹Gish RG \[[@CR65]\]2001✹✹✹✹✹✹✹✹✹Karman JF \[[@CR66]\]2001✹✹✹✹✹Mackie J \[[@CR15]\]2001✹✹✹✹✹✹✹✹Tome S \[[@CR67]\]2002✹✹✹✹✹Berlakovich GA \[[@CR68]\]2004✹✹✹✹✹✹✹Jauhar S \[[@CR14]\]2004✹✹✹✹✹✹Miguet M \[[@CR69]\]2004✹✹✹✹✹✹✹Björnsson E \[[@CR20]\]2005✹✹✹✹✹✹✹✹Cuadrado A \[[@CR10]\]2005✹✹✹✹✹✹✹✹✹DiMartini A \[[@CR70]\]2006✹✹✹✹✹✹✹Hwang S \[[@CR71]\]2006✹✹✹✹✹✹✹Kelly M \[[@CR72]\]2006✹✹✹✹✹✹✹✹✹De Gottardi A \[[@CR29]\]2007✹✹✹✹✹✹✹✹✹Dumortier J \[[@CR73]\]2007✹✹✹✹✹✹✹✹Newton SE \[[@CR74]\]2007✹✹✹✹✹Nickels M \[[@CR75]\]2007✹✹✹✹✹Pfitzmann R \[[@CR8]\]2007✹✹✹✹✹✹✹✹✹Vieira A \[[@CR76]\]2007✹✹✹✹✹Wells JT \[[@CR77]\]2007✹✹✹✹✹✹✹✹Gedaly R \[[@CR23]\]2008✹✹✹✹✹Immordino G \[[@CR17]\]2009✹✹✹✹✹Tandon P \[[@CR26]\]2009✹✹✹✹✹✹✹✹Biselli M \[[@CR78]\]2010✹✹✹✹✹✹✹✹Chen GH \[[@CR79]\]2010✹✹✹✹✹✹✹DiMartini A \[[@CR80]\]2010✹✹✹✹✹✹✹Karim Z \[[@CR81]\]2010✹✹✹✹✹✹✹✹Hartl J \[[@CR82]\]2011✹✹✹✹✹✹✹✹Mathurin P \[[@CR7]\]2011✹✹✹✹✹✹✹Schmeding M \[[@CR9]\]2011✹✹✹✹✹✹✹Staufer K \[[@CR83]\]2011✹✹✹✹✹✹✹Faure S \[[@CR84]\]2012✹✹✹✹✹✹✹✹Addolorato G \[[@CR85]\]2013✹✹✹✹✹✹✹✹Deruytter E \[[@CR86]\]2013✹✹✹✹✹✹✹✹✹Kawaguchi Y \[[@CR87]\]2013✹✹✹✹✹✹✹✹Park YH \[[@CR19]\]2013✹✹✹✹✹✹✹Rice JP \[[@CR88]\]2013✹✹✹✹✹✹✹Rodrigue JR \[[@CR89]\]2013✹✹✹✹✹✹✹✹✹Egawa H \[[@CR16]\]2014✹✹✹✹✹✹✹✹Grąt M \[[@CR90]\]2014✹✹✹✹✹✹Piano S \[[@CR91]\]2014✹✹✹✹✹✹✹Dumortier J \[[@CR92]\]2015✹✹✹✹✹✹✹✹Hasanin M \[[@CR93]\]2015✹✹✹✹✹Satapathy SK \[[@CR94]\]2015✹✹✹✹✹✹Zhou M \[[@CR28]\]2015✹✹✹✹✹✹✹✹Askgaard G \[[@CR95]\]2016✹✹✹✹✹✹✹✹Hajifathalian K \[[@CR96]\]2016✹✹✹✹✹Im GY \[[@CR97]\]2016✹✹✹✹✹✹Kollmann D \[[@CR98]\]2016✹✹✹✹✹✹✹✹Lee BP \[[@CR99]\]2017✹✹✹✹✹✹✹✹Onishi Y \[[@CR100]\]2017✹✹✹✹✹✹✹✹✹Wigg AJ \[[@CR101]\]2017✹✹✹✹✹✹✹✹✹

### Statistical analysis {#Sec11}

The rate of alcohol relapse after LT was estimated along with its 95% confidence interval (CI) for each study. The rate was then pooled across studies using a meta-analysis for pooling proportion \[[@CR102]\]. The random effect model was applied if there was heterogeneity between studies; otherwise, a fixed-effect model was applied. An odds ratio (OR) along with 95% CI of risk factor associated with alcohol relapse after LT was estimated for each study. Heterogeneity was assessed using the Cochrane Q test and the I^2^ statistic. Heterogeneity was present when the Q test was significant (*p* \< 0.1) or I^2^ ≥ 25%. The sources of heterogeneity were then explored using a meta-regression if the data of the co-variables were available. Subgroup analysis by age, region of study, definition of alcohol relapse, and follow-up time was then performed accordingly. Publication bias was assessed by Egger's test and a funnel plot. If there was asymmetry suggested from either a funnel plot or Egger's test, then a contour-enhanced funnel plot was used to explore whether the asymmetry was due to publication bias or heterogeneity. All analyses were performed using STATA software version 14.1. *P*-values \< 0.05 and \< 0.10 were considered statistically significant for a two-sided test and one-sided test, respectively.

Results {#Sec12}
=======

Search result {#Sec13}
-------------

A total of 291 studies were identified from PubMed and Scopus databases plus 30 additional studies from the reference lists (Fig. [1](#Fig1){ref-type="fig"}). The title and abstracts were reviewed for 321 studies; 123 duplicated studies, 1 meta-analysis, and 4 systematic reviews were removed \[[@CR25], [@CR103]--[@CR106]\]. The remaining 193 studies were reviewed in full text excluding 101 studies. Of the remaining studies, 90 reported the proportion of alcohol relapse, and 37 studies assessed risk factors of alcohol relapse. The kappa index between the two reviewers (L.C. and A.S.) was 0.96 for data extraction, which indicated very good inter-observer agreement. Fig. 1Protocol flow chart

Study characteristics {#Sec14}
---------------------

Of the 90 studies reporting alcohol relapse, 86 were cohort studies (72 retrospective and 14 prospective cohorts), 2 were cross-sectional studies, and 2 were case-control studies (Table [3](#Tab3){ref-type="table"}). Data for the 86 cohort studies were used for pooling in the incidence of alcohol relapse. Of these, 45 cohorts (40 retrospective and 5 prospective cohorts) were pooled for the proportion of heavy alcohol relapse; 37 studies (43.0%) were from North America, 40 studies (46.5%) were from Europe, 8 studies (9.3%) were from Asia-Pacific, and 1 study (0.1%) was from Brazil. Table 3Main characteristics of the studies included in the meta-analysisAuthorYearType of studyRegion of studyMean age (years)Number of populationNumber of any relapseNumber of heavy relapseFollow-up time (months)Starzl TE \[[@CR30]\]1988Retrospective CohortUS-Canada-352-24Bird GL \[[@CR12]\]1990Retrospective CohortEurope-184\--Kumar S \[[@CR31]\]1990Retrospective CohortUS-Canada48.2526225Doffoel M \[[@CR32]\]1992Retrospective CohortEurope-5719\--Knechtle SJ \[[@CR33]\]1992Case-controlUS-Canada51324\--Lucey MR \[[@CR34]\]1992Retrospective CohortUS-Canada44455215Berlakovich GA\[[@CR35]\]1994Retrospective CohortEurope47.64414733Howard L \[[@CR36]\]1994Retrospective CohortEurope5020191634Osorio RW \[[@CR37]\]1994Prospective CohortUS-Canada47377321Gerhardt TC \[[@CR38]\]1996Retrospective CohortUS-Canada494120247Tringali RA \[[@CR39]\]1996Retrospective CohortUS-Canada47.458121028Tripp LE \[[@CR40]\]1996Retrospective CohortUS-Canada496895-Zibari GB \[[@CR41]\]1996Retrospective CohortUS-Canada47292\--Anand AC \[[@CR42]\]1997Retrospective CohortEurope47.5395-25Coffman KL \[[@CR43]\]1997Prospective CohortUS-Canada-9118\--Everson G \[[@CR44]\]1997Retrospective CohortUS-Canada536211612Foster PF \[[@CR24]\]1997Retrospective CohortUS-Canada48.66313-49.3Lucey MR \[[@CR45]\]1997Retrospective CohortUS-Canada465017-63Reeck UH \[[@CR46]\]1997Retrospective CohortEurope-526\--Shakil AO \[[@CR47]\]1997Retrospective CohortUS-Canada4183\--Stefanini GF \[[@CR48]\]1997Retrospective CohortEurope47113148DiMartini A \[[@CR49]\]1998Retrospective CohortUS-Canada49.56315\--Fabrega E \[[@CR50]\]1998Retrospective CohortEurope49448-37.8Heinemann A \[[@CR51]\]1998Retrospective CohortEurope45.6134\--Tang H \[[@CR52]\]1998Retrospective CohortEurope485628924Conjeevaram HS \[[@CR53]\]1999Retrospective CohortUS-Canada476888-Gledhill J \[[@CR54]\]1999Retrospective CohortEurope48317-13.5Newton SE \[[@CR55]\]1999Retrospective CohortUS-Canada4712233-62Pageaux GP \[[@CR18]\]1999Retrospective CohortEurope48.84715542.1Romano DR \[[@CR56]\]1999Case-controlEurope47.61527\--Abosh D \[[@CR57]\]2000Retrospective CohortUS-Canada50105510Berlakovich GA \[[@CR58]\]2000Retrospective CohortEurope-11815-53.7Burra P \[[@CR59]\]2000Prospective CohortAsia Pacific483411440.1DiMartini A \[[@CR60]\]2000Retrospective CohortEurope507241-Jain A \[[@CR61]\]2000Retrospective CohortUS-Canada50.818537194Pereira SP \[[@CR62]\]2000Retrospective CohortEurope5156281530Platz KP \[[@CR21]\]2000Retrospective CohortEurope-11730\--Bellamy CO \[[@CR63]\]2001Retrospective CohortUS-Canada5312313-84DiMartini A \[[@CR64]\]2001Prospective CohortUS-Canada-368\--Gish RG \[[@CR65]\]2001Prospective CohortUS-Canada476112-82.8Karman JF \[[@CR66]\]2001Retrospective CohortUS-Canada49194-36Mackie J \[[@CR15]\]2001Retrospective CohortEurope514621325Tome S \[[@CR67]\]2002Prospective CohortEurope51687238Berlakovich GA \[[@CR68]\]2004Case-controlEurope51.5443-43.5Jauhar S \[[@CR14]\]2004Retrospective CohortUS-Canada5111171544.1Miguet M \[[@CR69]\]2004Prospective CohortEurope48.75113935.7Björnsson E \[[@CR20]\]2005Retrospective CohortEurope539332731Cuadrado A \[[@CR10]\]2005Retrospective CohortEurope48.954141499.2DiMartini A \[[@CR70]\]2006Prospective CohortUS-Canada49.71677043-Hwang S \[[@CR71]\]2006Retrospective CohortUS-Canada50153-41Kelly M \[[@CR72]\]2006Retrospective CohortAsia Pacific50.190281867De Gottardi A \[[@CR29]\]2007Retrospective CohortEurope51.3387464661.2Dumortier J \[[@CR73]\]2007Retrospective CohortEurope50305373763Newton SE \[[@CR74]\]2007Cross sectionalUS-Canada-184\--Nickels M \[[@CR75]\]2007Retrospective CohortUS-Canada48.8278-23.4Pfitzmann R \[[@CR8]\]2007Retrospective CohortEurope51.2290562389Vieira A \[[@CR76]\]2007Retrospective CohortOther(Brazil)47172-29.6Wells JT \[[@CR77]\]2007Retrospective CohortEurope50.3148242090.5Gedaly R \[[@CR23]\]2008Retrospective CohortUS-Canada5214227-41.2Immordino G \[[@CR17]\]2009Retrospective CohortUS-Canada53.211013\--Tandon P \[[@CR26]\]2009Retrospective CohortUS-Canada52171412264.8Biselli M \[[@CR78]\]2010Retrospective CohortEurope484913358Chen GH \[[@CR79]\]2010Retrospective CohortAsia Pacific52.8161-32.4DiMartini A \[[@CR80]\]2010Prospective CohortUS-Canada5220895\--Karim Z \[[@CR81]\]2010Retrospective CohortUS-Canada50.58088-Hartl J \[[@CR82]\]2011Retrospective CohortEurope52.510917-31Mathurin P \[[@CR7]\]2011Prospective CohortEurope47.4263220Schmeding M \[[@CR9]\]2011Retrospective CohortEurope48.92717373-Staufer K \[[@CR83]\]2011Prospective CohortEurope53.514128\--Faure S \[[@CR84]\]2012Retrospective CohortEurope51206905081.7Addolorato G \[[@CR85]\]2013Retrospective CohortEurope49.49222\--Deruytter E \[[@CR86]\]2013Retrospective CohortEurope56108311755Kawaguchi Y \[[@CR87]\]2013Retrospective CohortAsia Pacific52131-38Park YH \[[@CR19]\]2013Retrospective CohortAsia Pacific52183257Rice JP \[[@CR88]\]2013Retrospective CohortUS-Canada49.3300481682Rodrigue JR \[[@CR107]\]2013Retrospective CohortUS-Canada55118401255Egawa H \[[@CR16]\]2014Retrospective CohortAsia Pacific35140322144Grąt M \[[@CR90]\]2014Retrospective CohortEurope466622-88.8Piano S \[[@CR91]\]2014Prospective CohortEurope60235\--Dumortier J \[[@CR92]\]2015Retrospective CohortEurope47.271212812863Hasanin M \[[@CR93]\]2015Cross-sectionalUS-Canada-458\--Satapathy SK \[[@CR94]\]2015Retrospective CohortUS-Canada541481616112.8Zhou M \[[@CR28]\]2015Retrospective CohortUS-Canada54.2356\--Askgaard G \[[@CR95]\]2016Retrospective CohortEurope541563535-Hajifathalian K \[[@CR96]\]2016Prospective CohortEurope56194-40.8Im GY \[[@CR97]\]2016Retrospective CohortUS-Canada4192124.5Kollmann D \[[@CR98]\]2016Retrospective CohortEurope-38216-73Lee BP \[[@CR99]\]2017Retrospective CohortUS-Canada51.43111719.2Onishi Y \[[@CR100]\]2017Retrospective CohortAsia Pacific4671-60Wigg AJ \[[@CR101]\]2017Retrospective CohortAsia Pacific5087181452

The incidence of alcohol relapse {#Sec15}
--------------------------------

The characteristics of the studies and the data on alcohol relapse rates are detailed in Table [3](#Tab3){ref-type="table"}. A total of 86 cohort studies with 8061 patients reported incidences of alcohol relapse at any time after LT. The mean age of patients ranged from 35 to 60 years, and the mean follow-up time was 10 to 112 months. The alcohol relapse rate varied across studies with a range of 4 to 95% with an I^2^ of 90.7%. A random effect model was applied and yielded the pooled alcohol relapse rate of 22% (95% CI: 19--25%) during the mean follow-up time of 48.4 ± 24.7 months. The rate of heavy alcohol relapse varied markedly across studies with an I^2^ of 85% and pooled rate of 14% (95%CI: 12--16%).

Pooled risk factors of alcohol relapse {#Sec16}
--------------------------------------

The effects of all of the risk factors on alcohol relapse after LT that were classified by demographic, risk behavior, social, and comorbidity factors; these were pooled in 37 cohort studies (Table [4](#Tab4){ref-type="table"}). The results of pooling these effects are summarized in Table [5](#Tab5){ref-type="table"}. The results showed that psychiatric comorbidities, pre-transplant abstinence less than 6 months, being unmarried, and smoking were significantly associated with alcohol relapse after LT with corresponding pooled ORs of 3.46 (95% CI: 1.87--6.39), 2.76 (95%CI: 2.10--3.61), 1.84 (95%CI: 1.39--2.43), and 1.72 (95%CI: 1.21--2.46), respectively. In addition, the I^2^ ranged from 0 to 40.6%, with the highest I^2^ in psychiatric comorbidities. Table 4Summary of the included studies reported risk factors in the meta-analysisAuthorYearDemographic factorsRisk behavior factorsSocial factorsComorbidityKumar S \[[@CR31]\]1990\--Abstinence \< 6months-Osorio RW \[[@CR37]\]1994MaleUnmarriedUnemployedSubstance useAbstinence \< 6monthsRehabilitationPsychiatric diseaseGerhardt TC \[[@CR38]\]1996\--Abstinence \< 6months-Tringali RA \[[@CR39]\]1996\--Abstinence \< 6months-Foster PF \[[@CR24]\]1997Family history of alcohol useSubstance useAbstinence \< 6monthsRehabilitation-Lucey MR \[[@CR45]\]1997Male-Abstinence \< 6months-Shakil AO \[[@CR47]\]1997Male\-\--Tang H \[[@CR52]\]1998Male\-\--Conjeevaram HS \[[@CR53]\]1999Male\-\--Newton SE \[[@CR55]\]1999-Substance use\--Pageaux GP \[[@CR18]\]1999MaleUnmarriedUnemployed-Abstinence \< 6months-Burra P \[[@CR59]\]2000UnmarriedFamily history of alcohol useSubstance useAlcohol dependenceRehabilitation-Jain A \[[@CR61]\]2000\--Abstinence \< 6monthsRehabilitation-Mackie J \[[@CR15]\]2001MaleUnmarriedLack of social supportLow SESFamily history of alcohol useSmokingAbstinence \< 6months-Jauhar S \[[@CR14]\]2004MaleUnmarriedUnemployedSubstance useAbstinence \< 6monthsRehabilitationPsychiatric diseaseBjörnsson E \[[@CR20]\]2005\--Rehabilitation-Cuadrado A \[[@CR10]\]2005Male\--Hwang S \[[@CR71]\]2006\--Abstinence \< 6months-Kelly M \[[@CR72]\]2006UnmarriedLack of social supportUnemployedSubstance useAbstinence \< 6monthsPsychiatric diseaseDepressionDe Gottardi A \[[@CR29]\]2007Age \< 50 yearsMaleUnmarriedLow SESUnemployedHigh HRARAbstinence \< 6monthsPsychiatric diseaseNickels M \[[@CR75]\]2007Age \< 50 yearsMaleAlcohol dependence-DepressionPfitzmann R \[[@CR8]\]2007Age \< 50 yearsMaleUnmarried-Abstinence \< 6months-Karim Z \[[@CR81]\]2010Age \< 50 yearsMaleUnmarriedLow SESUnemployedSmokingSubstance useAbstinence \< 6monthsRehabilitationPsychiatric diseaseHartl J \[[@CR82]\]2011-SmokingAbstinence \< 6monthsRehabilitation-Addolorato G \[[@CR85]\]2013\--Rehabilitation-Deruytter E \[[@CR86]\]2013Age \< 50 yearsMaleUnmarriedUnemployedFamily history of alcohol useSmokingAlcohol dependence-Psychiatric diseaseKawaguchi Y \[[@CR87]\]2013MaleHigh HRAR\--Park YH \[[@CR19]\]2013Male-Abstinence \< 6months-Rice JP \[[@CR88]\]2013Male\-\--Rodrigue JR \[[@CR89]\]2013Lack of social supportSmokingAbstinence \< 6monthsRehabilitation-Egawa H \[[@CR16]\]2014MaleUnmarriedLack of social supportUnemployedSmokingHigh HRARAbstinence \< 6monthsPsychiatric diseaseZhou M \[[@CR28]\]2015-High HRAR\--Askgaard G \[[@CR95]\]2016MaleUnmarriedUnemployedFamily history of alcohol useSmokingAlcohol dependenceAbstinence \< 6 monthsDepressionIm GY \[[@CR97]\]2016MaleUnmarriedFamily history of alcohol useSmoking-Psychiatric diseaseLee BP \[[@CR99]\]2017Male\-\--Onishi Y \[[@CR100]\]2017Age \< 50 yearsMale\-\--Wigg AJ \[[@CR101]\]2017MaleUnmarriedLack of social supportUnemployedFamily history of alcohol useSmokingSubstance useRehabilitationPsychiatric disease Table 5Pooled risk factors of alcohol relapseFactorsNOR95%CIPooling methodI^2^Egger test (P-value)Demographic factors Age \< 50 years61.160.43 - 3.15Random effect75.20.55 Sex (male)230.890.69 - 1.11Fixed effect21.70.43 Unmarried141.841.39 - 2.43Fixed effect14.60.57 Lack of social support51.780.72 - 4.38Random effect49.50.18 Low SES30.990.15 - 6.50Random effect86.30.28 Unemployed101.330.93 - 1.89Fixed effect7.70.74 Family history of alcohol use71.490.94 - 2.36Fixed effect23.00.50Risk behavior factors Smoking91.721.21 - 2.46Fixed effect00.69 Substance use81.060.48 - 2.34Random effect58.50.71 Alcohol dependence41.220.43 - 3.40Random effect61.80.15 High HRAR42.930.30 - 28.64Random effect79.60.18Social factors Abstinence \< 6 months202.762.10 - 3.61Fixed effect18.10.02 Rehabilitation program111.100.59 - 2.04Random effect670.71Comorbidity Psychiatric disease93.461.87 - 6.39Random effect40.60.02 Depression32.130.49 - 9.25Random effect54.40.60*N* Number, *OR* Odds ratio, *CI* Confidence interval, *I*^*2*^ I^2^statistics, *SES* Socioeconomic status, *HRAR* High-risk alcohol relapse scale

Subgroup analysis {#Sec17}
-----------------

Subgroup analysis by age (≤ 50 years or \> 50 years), regions of studies (Europe, North America, Asia Pacific and Brazil), definition of alcohol relapse (only report or report combining with biochemical testing), and follow-up time (≤ 4 years or \> 4 years) was performed to explore the potential cause of heterogeneity of pooled rates of alcohol relapse and heavy alcohol relapse. Likewise, the subgroup analysis was performed with psychiatric comorbidities to identify the factor associated with alcohol relapse with the highest risk and heterogeneity. Subgroup analyses showed no significant difference in all analyses of alcohol relapse and heavy alcohol relapse rates except for one analysis of psychiatric comorbidities. Patients with psychiatric comorbidities who had longer follow-up time (\> 4 years) had an increased risk of alcohol relapse versus those with a shorter follow-up time (≤ 4 years) (Fig. [2](#Fig2){ref-type="fig"}). Fig. 2Subgroup analysis of duration of follow-up time in psychiatric comorbidity factor

Publication bias {#Sec18}
----------------

The Egger test showed no evidence of publication bias among the studies, and the shape of the funnel plots was symmetrical in all analyses except for psychiatric comorbidities (Fig. [3](#Fig3){ref-type="fig"}) and abstinence less than 6 months (Fig. [4](#Fig4){ref-type="fig"}). The studies that reported less than 6 months of abstinence were both non-significant and significant leading to a contour-enhanced funnel plot; thus, asymmetry may not be due to either publication bias or heterogeneity. The studies with negative effect of psychiatric co-morbidities and abstinence less than 6 months were not reported. Fig. 3Funnel plot and contour-enhanced funnel plot for psychiatric comorbidities Fig. 4Funnel plot and contour-enhanced funnel plot for less than 6 months of pre-transplant abstinence

Discussion {#Sec19}
==========

Alcohol relapse after LT remains an ethical issue in LT for alcoholic liver disease due to its harmful and negative impacts on liver grafts. One meta-analysis and four systemic reviews of alcoholic liver disease in LT patient were published earlier \[[@CR25], [@CR103]--[@CR106]\]. The well-designed meta-analysis of rate and risk factors of alcohol relapse by Dew et al. in 2008 included 54 studies published between 1983 and 2005 \[[@CR25]\]. A systematic review by Rustard et al. in 2015 selected only articles of the risk factors of alcohol relapse \[[@CR103]\]. A systematic review by McCallum et al. in 2006 included only studies that were associated with psychosocial criteria \[[@CR106]\]. Bravata et al. performed a systematic review of alcohol relapse and evaluated only the association between employment aspect and alcohol relapse \[[@CR105]\]. One systematic review focused on neither alcohol relapse rate nor risk factor \[[@CR104]\]. Our study is a systematic review and meta-analysis of all published studies up to 2018, which aimed to estimate post-LT alcohol relapse rate and its predictive factors. To date, the current study is the most extensive meta-analysis of alcohol relapse in LT patients.

Our study demonstrated that any alcohol relapse and heavy alcohol relapse rates were as high as 22 and 14% during the mean follow-up time of 48.4 ± 24.7 months, respectively. The literature on alcohol relapse post-transplantation has reported a wide range of alcohol relapse rates, which might be due to different definitions of alcohol relapse. Dew et al. reported that the average rate for alcohol relapse after LT was 5.6 cases per 100 patients per year for any alcohol relapse and 2.5 cases per 100 patients per year for heavy alcohol relapse \[[@CR25]\]. The authors suggested that a significant proportion of patients who returned to any alcohol drinking then became heavy drinkers, which led to a significant harm to LT recipients \[[@CR25]\].

In our study, the most significant risk factors of relapse were psychiatric comorbidities followed by pre-transplant alcohol abstinence less than 6 months, being unmarried, and smoking. Four of the nine studies reported that psychiatric conditions had a link with alcohol relapse \[[@CR16], [@CR29], [@CR72], [@CR81]\]. The finding was consistent with the previous meta-analysis \[[@CR25]\]. The study identified 3 of the 12 psychosocial variables associated with any alcohol relapse: \< 6 months abstinence prior to transplant, poor social support, and a family history of alcohol abuse or dependence \[[@CR25]\]. We found that 9 of the 20 studies revealed that alcohol abstinence less than 6 months was associated with alcohol relapse \[[@CR8], [@CR18], [@CR29], [@CR37], [@CR81], [@CR82], [@CR95], [@CR107], [@CR108]\]. Our study confirms the validity of using the 6-month rule of alcohol abstinence as a criterion for pre-transplant selection in patients with ALD; this is consistent with the previous meta-analysis study \[[@CR25]\].

A systematic review of large prospective studies focusing on risk factors for alcohol relapse following LT has also suggested that a shorter length of pre-transplant sobriety was a significant predictor of alcohol relapse \[[@CR103]\]. However, the 6-month rule cannot be applied in LT for patients with severe acute alcoholic hepatitis whose condition is not allowed to wait until 6 months. LT in this group of patients remains a controversial issue in many transplant centers. The current data do not suggest that LT in patients with severe alcoholic hepatitis leads to more alcohol relapse \[[@CR109]\]. Therefore, 6 months of alcohol abstinence may not reliably predict post-LT alcohol relapse. Other risk factors were psychiatric comorbidities, a high score on the HRAR scale, and a diagnosis of alcohol dependence \[[@CR103]\]. Scoring systems to predict alcohol relapse after LT such as HRAR and the ARRA were proposed for use, but they have never been validated by well-designed studies.

In this study, psychiatric co-morbidities and pre-transplant abstinence less than 6 months were strong predictive factors of alcohol relapse with some publication bias against negative studies. Psychiatric comorbidities were the strongest risk factor in this study but with high heterogeneity. Interestingly, subsequent subgroup analysis showed that longer follow-up times led to an increased impact of psychiatric comorbidities on any alcohol relapse. The psychiatric comorbidities defined in enrolled studies included all psychiatric conditions that could cause impaired daily functioning, i.e. anxiety, schizophrenia, and personality disorders. In this study, we analyzed three cohort studies that reported depression separately because depression is a known risk factor associated with alcoholic drinking. We found that depression was not a significant factor in alcohol relapse (OR = 3; 95%CI 0.49--9.25).

Clinical practice has changed considerably since the first studies that recruited in 1988. The differences in the definition of alcohol relapse and heavy relapse as well as a lack of objective means of documenting alcohol use in these studies are limitations. Furthermore, heavy alcohol relapse was defined only in some studies (Table [2](#Tab2){ref-type="table"}). Including unpublished studies may solve this problem. The absence of negative studies of psychiatric co-morbidities and abstinence less than 6 months likely caused publication bias. However, this attempt cannot guarantee a reasonably low heterogeneity after including unpublished studies.

Conclusions {#Sec20}
===========

We demonstrated the pooled rates of any alcohol relapse and heavy alcohol relapse post-LT. Furthermore, we identified predictive factors of alcohol relapse after LT to be used during the selection process of LT candidates. With respect to the prevention of alcohol relapse post-LT, alcohol abstinence of at least 6 months, appropriate screening and care of psychiatric co-morbidities, and smoking cessation should be incorporated in pre-transplant selection and management periods. Careful selection of LT candidates and modifying pre-transplant risk factors of alcohol relapse has the potential to reduce alcohol relapse after LT.

ALD

:   Alcoholic liver disease

CI

:   Confidence interval

HRAR

:   High-Risk Alcohol Relapse

LT

:   Liver transplantation

OR

:   Odds ratio
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